Sinovac Biotech
-
{
- All
- News
-
Sinovac Vaccine Antibody Levels May Decline In 6 Months, Booster Helps: Study
- Thursday August 12, 2021
- World News | Reuters
Antibodies triggered by Sinovac Biotech's COVID-19 vaccine declined below a key threshold from around six months after a second dose for most recipients, but a third shot had a strong booster effect, a lab study showed.
-
www.ndtv.com
-
Chinese Sinovac Shot Seen As Highly Effective In Study
- Wednesday May 12, 2021
- World News | Bloomberg News
Sinovac Biotech Ltd.'s vaccine is wiping out Covid-19 among health workers in Indonesia, an encouraging sign for the dozens of developing countries reliant on the controversial Chinese shot, which performed far worse than western vaccines in clinical
-
www.ndtv.com
-
This Vaccine Cuts By 50% Risk of Symptomatic Covid: Study
- Monday April 12, 2021
- World News | Michelle Fay Cortez, Bloomberg
Sinovac Biotech Ltd.'s coronavirus vaccine cut in half the risk of developing symptomatic Covid-19 in a key Brazilian study, suggesting two doses of the shot is less potent than some other immunizations designed to tame the ongoing pandemic.
-
www.ndtv.com
-
China Approves Sinovac Biotech Coronavirus Vaccine For General Public Use
- Saturday February 6, 2021
- World News | Reuters
Sinovac Biotech said on Saturday that its unit's COVID-19 vaccine has been formally approved for use by the general public by China's medical products regulator.
-
www.ndtv.com
-
Sinovac Vaccine Antibody Levels May Decline In 6 Months, Booster Helps: Study
- Thursday August 12, 2021
- World News | Reuters
Antibodies triggered by Sinovac Biotech's COVID-19 vaccine declined below a key threshold from around six months after a second dose for most recipients, but a third shot had a strong booster effect, a lab study showed.
-
www.ndtv.com
-
Chinese Sinovac Shot Seen As Highly Effective In Study
- Wednesday May 12, 2021
- World News | Bloomberg News
Sinovac Biotech Ltd.'s vaccine is wiping out Covid-19 among health workers in Indonesia, an encouraging sign for the dozens of developing countries reliant on the controversial Chinese shot, which performed far worse than western vaccines in clinical
-
www.ndtv.com
-
This Vaccine Cuts By 50% Risk of Symptomatic Covid: Study
- Monday April 12, 2021
- World News | Michelle Fay Cortez, Bloomberg
Sinovac Biotech Ltd.'s coronavirus vaccine cut in half the risk of developing symptomatic Covid-19 in a key Brazilian study, suggesting two doses of the shot is less potent than some other immunizations designed to tame the ongoing pandemic.
-
www.ndtv.com
-
China Approves Sinovac Biotech Coronavirus Vaccine For General Public Use
- Saturday February 6, 2021
- World News | Reuters
Sinovac Biotech said on Saturday that its unit's COVID-19 vaccine has been formally approved for use by the general public by China's medical products regulator.
-
www.ndtv.com